Press release
Rising Prevalence Of Alzheimer's Disease To Drive Market Growth: A Key Driver Powering Alzheimer's Drugs Market Growth In 2025
Alzheimer's Drugs
What Is the Current Alzheimer's Drugs Market Size and Its Estimated Growth Rate?
The market size for Alzheimer's medication has seen robust expansion in the past few years. Forecasts predict an increase from $9.33 billion in 2024 to $10.19 billion by 2025, marking a compound annual growth rate (CAGR) of 9.1%. The growth witnessed in the historical period can be tied to an uptick in Alzheimer's disease cases, sustained funding in scientific investigation and development, a deeper comprehension of disease mechanisms, internationally coordinated health programs, and increased public awareness and education.
The market size for Alzheimer's medications is projected to experience robust growth over the next few years, increasing to approximately $14.47 billion in 2029 with a compound annual growth rate (CAGR) of around 9.2%. This predicted growth during the forecast period can be connected to the adoption of precision medicine approaches, attention given to disease modification, the identification and validation of biomarkers, patient-centric drug design, and the focus on non-pharmaceutical interventions. Major market trends for the forecast period include varied therapeutic tactics, digital health tools, regenerative medicine, breakthroughs in diagnostic technologies, the use of artificial intelligence (AI) in the development of new medications, and strategic partnerships and collaborations.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9040
How Are Emerging Segments Shaping the Alzheimer's Drugs Market Landscape?
The alzheimer's drugs market covered in this report is segmented -
1) By Drugs: Donepezil, Rivastigmine, Galantamine, Memantine
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Application: Early To Moderate Stages, Moderate To Severe Stages
Subsegments:
1) By Donepezil: Oral Tablets, Oral Solution
2) By Rivastigmine: Oral Capsules, Oral Solution, Transdermal Patches
3) By Galantamine: Oral Tablets, Oral Solution, Extended-Release Capsules
4) By Memantine: Oral Tablets, Oral Solution, Extended-Release Capsules
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9040&type=smp
Which Growth Factors Are Influencing Alzheimer's Drugs Market Expansion?
The anticipated escalation in cases of Alzheimer's disease is likely to drive the Alzheimer's drugs market's growth. Alzheimer's disease, a progressive neurological disorder, leads to shrinkage of the brain and cell death over time. Drugs designed to treat Alzheimer's focus on addressing memory loss, difficulty with cognitive processes, and the challenges of day-to-day living. Such Alzheimer's drugs can significantly improve patients' quality of life and help them maintain their independence. For example, a report by the Alzheimer's Association, a US nonprofit organization in Alzheimer's care, support, and research, in May 2024 revealed an increase in Alzheimer's dementia cases among Americans aged 65 and above from 6.5 million in 2022 to a projected 6.9 million in 2024. Consequently, the rising incidence of Alzheimer's is fueling the expansion of the Alzheimer's drugs market.
Who Are the Dominant Players Across Different Alzheimer's Drugs Market Segments?
Major companies operating in the alzheimer's drugs market include AbbVie Inc., Daiichi Sankyo Company Limited, F Hoffmann-La Roche AG, Merck & Co Inc., Novartis AG, Biogen Inc., AstraZeneca PLC, Eisai Co Ltd., Eli Lilly and Company, H Lundbeck A/S, Pfizer Inc., Allergan PLC., Johnson & Johnson, Lupin Pharmaceuticals Inc., Actiza Pharmaceutical Private Limited, Neurotrope Inc., AC Immune SA, Adamas Pharmaceuticals Inc, Alzheon Inc., Anavex Life Sciences Corp, Axsome Therapeutics Inc., Cassava Sciences Inc., Cognition Therapeutics Inc., Cortexyme Inc., Denali Therapeutics Inc, EIP Pharma Inc., Enlivex Therapeutics Ltd., FORUM Pharmaceuticals Inc., Genentech Inc., Green Valley Pharmaceuticals LLC, Intra-Cellular Therapies Inc., Karuna Therapeutics Inc., Neurim Pharmaceuticals Ltd
What Are the Latest Developing Trends in the Alzheimer's Drugs Market?
Leading firms in the Alzheimer's drugs industry are concentrating on the creation of novel products, such as therapies that target amyloid plaque, to improve treatments and patient recovery. The amyloid plaque-targeting therapy is a treatment strategy for Alzheimer's disease that aims to decrease or inhibit the buildup of amyloid-beta plaques in the brain. For example, in June 2024, Eli Lilly and Company, a pharmaceutical company based in the US, received the approval for Kisunla (donanemab-azbt) from the Food and Drug Administration (FDA), the US federal agency responsible for public health protection. Kisunla (donanemab-azbt) stands out as the first and only treatment focusing on amyloid plaque for the early symptomatic phase of Alzheimer's disease. It functions by assisting the body in eliminating excess amyloid plaques from the brain connected with cognitive deterioration in Alzheimer's patients. Kisunla is given as an intravenous infusion every four weeks. The initial dose includes 700 mg for the initial three doses, followed by 1400 mg for subsequent doses. Kisunla is specifically recommended for adults with mild cognitive impairment (MCI) and minor Alzheimer's disease dementia stages, only if they have confirmed amyloid pathology.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report
Which Geographic Regions Are Expected to Dominate the Alzheimer's Drugs Market in the Coming Years?
North Americawas the largest region in the Alzheimer's drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the Alzheimer's drugs market during the forecast period. The regions covered in the Alzheimer's drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Alzheimer's Drugs Market?
2. What is the CAGR expected in the Alzheimer's Drugs Market?
3. What Are the Key Innovations Transforming the Alzheimer's Drugs Industry?
4. Which Region Is Leading the Alzheimer's Drugs Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence Of Alzheimer's Disease To Drive Market Growth: A Key Driver Powering Alzheimer's Drugs Market Growth In 2025 here
News-ID: 3976898 • Views: …
More Releases from The Business Research Company
Future Perspective: Key Trends Shaping the Signal Conditioning Modules Market Up …
The signal conditioning modules market is on track for significant expansion over the coming years, driven by advancements in various industrial and technological sectors. This growth reflects the increasing need for precise signal management and integration with emerging smart technologies that are shaping modern automation and data acquisition systems.
Projected Growth Trajectory of the Signal Conditioning Modules Market
The signal conditioning modules market is anticipated to reach a valuation of $1.77…
Emerging Sub-Segments Transforming the Set-Top Box Market Dynamics
The set-top box market is on the cusp of significant expansion as technology and consumer preferences continue to evolve rapidly. With the increasing demand for advanced streaming and broadcasting solutions, this sector is poised for substantial growth over the coming years. Let's explore the market's projected size, leading companies, key trends, and the segments driving this development.
Projected Market Growth of the Set-Top Box Industry by 2030
The set-top box market…
Market Trend Analysis: The Impact of Recent Innovations on the Semiconductor Waf …
The semiconductor wafer sector is gearing up for significant expansion as technological advancements and diverse industry demands drive its growth. With applications spanning from electric vehicles to telecommunications, this market is positioned for steady development in the years ahead. Let's explore the anticipated market size, key players, emerging trends, and segmentation details shaping the future of this vital industry.
Projected Market Size and Growth Trajectory of the Semiconductor Wafer Market
Forecasts…
Leading Companies Reinforce Their Presence in the Semiconductor Manufacturing Eq …
The semiconductor manufacturing equipment market is poised for significant expansion as the demand for high-performance chips and advanced packaging technologies continues to grow. This evolving sector is driven by technological progress and increased investments, setting the stage for substantial developments through 2030.
Projected Semiconductor Manufacturing Equipment Market Size and Growth
The semiconductor manufacturing equipment market is forecasted to reach a value of $196.07 billion by 2030, growing at a compound annual…
More Releases for Alzheimer
Alzheimer Therapeutics Market Breakthrough Innovations and Increasing Treatment …
The Alzheimer Therapeutics Market is rapidly evolving as disease-modifying therapies, early-stage diagnostic tools, and biomarker-driven treatment approaches reshape global management of Alzheimer's disease (AD). As one of the most prevalent neurodegenerative conditions, Alzheimer's affects millions of older adults worldwide. With recent regulatory approvals of anti-amyloid monoclonal antibodies, enhanced imaging technology, and increased R&D investment, the market is experiencing unprecedented momentum.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/51928
Key Takeaways
• Disease-modifying…
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
